Quantitative sensory testing
Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology
M.E. Shy, MD,
E.M. Frohman, MD PhD,
Y.T. So, MD PhD,
J.C. Arezzo, PhD,
D.R. Cornblath, MD,
M.J. Giuliani, MD,
J.C. Kincaid,
J.L. Ochoa, MD PhD, DSC,
G.J. Parry, MD and
L.H. Weimer, MD
From the Departments of Neurology and Center for Molecular Medicine and Genetics (Dr. Shy), Wayne State University School of Medicine, Detroit, MI; Department of Neurology (Dr. Frohman), UT Southwestern Medical Center, Dallas, TX; Department of Neurology and Neurosciences (Dr. So), Stanford University Medical Center, CA; Department of Neuroscience (Dr. Arezzo), Albert Einstein College of Medicine, New York, NY; Department of Neurology (Dr. Cornblath), Johns Hopkins University School of Medicine, Baltimore, MD; Clinical Research and Development (Dr. Giuliani), Wyeth-Ayerst, Collegeville, PA; Department of Neurology (J.C. Kincaid), University of Indiana School of Medicine, Indianapolis; Department of Neurology (Dr. Ochoa), University of Oregon, Portland; Department of Neurology (Dr. Parry), University of Minnesota, Minneapolis; and Department of Neurology (Dr. Weimer), Columbia Presbyterian Medical Center, New York, NY.

View larger version (13K):
[in a new window]
|
Figure. Summary of the methods of (A) "limits" and (B) "levels."
|
|
Copyright © 2003 by AAN Enterprises, Inc.